Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The "Standard group" refers to the control arm of a clinical trial (NCT02683330) conducted by the University of Sao Paulo General Hospital, investigating the efficacy of preemptive analgesia for postoperative pain management in patients undergoing arthroscopic rotator cuff repair. This protocol involves a two-stage process: an initial ultrasound examination of the brachial plexus performed 48 hours prior to surgery (without drug administration), followed by a standard ultrasound-guided brachial plexus blockade and sedation on the day of the operation. The blockade typically utilizes local anesthetics to provide regional anesthesia and analgesia. The study compares this standard-of-care approach against a preemptive group that receives an active blockade 48 hours earlier, aiming to evaluate the impact on central and peripheral nociceptive sensitization and subsequent postoperative opioid requirements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on standard group-University of Sao Paulo General Hospital-postoperative pain.